Colorectal Cancer Rates Rising Among Adults Under 50

Colorectal cancer, long considered a disease primarily affecting older adults, is increasingly being diagnosed in younger individuals. Health experts and researchers are observing a concerning trend: a significant rise in colorectal cancer rates among those under the age of 50. This shift has prompted investigations into potential causes and adjustments to screening guidelines.

A Growing Concern

Multiple studies and reports have highlighted the increasing incidence of early-onset colorectal cancer (EOCRC). The American Cancer Society (ACS) reported that in 2019, 20% of colorectal cancer diagnoses were in patients under 55, nearly double the rate observed in 1995. This rise is not limited to the United States; a study in The Lancet Oncology found increasing rates in 27 of 50 countries studied. In 14 of those countries, including the U.S., rates are increasing in young adults while stabilizing in older adults. Projections estimate that by 2030, colorectal cancer will be the leading cause of cancer death for people under 50.

Potential Risk Factors

While the exact reasons for this increase remain unclear, researchers have identified several potential contributing factors. These include:

• Lifestyle and Diet: Changes in lifestyle and dietary habits are strongly suspected. Increased consumption of processed foods, high-fat, high-sugar, and low-fiber diets, and the rise in sedentary behavior are all considered potential contributors. Some studies have linked a "Western diet" to an increased risk of early-onset colorectal adenomas.
• Obesity: Obesity has been identified as an independent risk factor for colorectal cancer. It can induce an inflammatory state in the body, potentially damaging cellular DNA and promoting cell proliferation.
• Alcohol and Tobacco Use: Heavy alcohol consumption and smoking are also associated with an increased risk.
• Gut Microbiome: Changes in the gut microbiome, potentially influenced by diet and lifestyle, are being investigated as a possible factor.
• Genetics: While most EOCRC cases are not linked to known hereditary syndromes, a significant proportion of younger patients have a genetic predisposition. Conditions like Lynch syndrome and familial adenomatous polyposis (FAP) increase the risk. A family history of colorectal cancer, especially in a first-degree relative diagnosed before age 50, significantly elevates an individual's risk. A Cleveland Clinic study identified family history, BMI, sex, and smoking as key factors associated with early-onset colorectal cancer and precancerous polyps.

Symptoms and Diagnosis

Early detection is crucial for successful treatment of colorectal cancer. However, symptoms can be subtle and easily dismissed, leading to delays in diagnosis. Common symptoms to watch out for include:

• Rectal bleeding or blood in the stool
• Changes in bowel habits (diarrhea, constipation, or changes in stool consistency)
• Abdominal pain or cramping
• Unexplained weight loss
• Fatigue or weakness
• Iron deficiency anemia

It's important to note that some individuals may experience no symptoms at all, particularly in the early stages of the disease. Yale Medicine surgeons urge individuals younger than 45 to discuss any suspicious symptoms with their doctors.

Screening Recommendations

In response to the rising rates of EOCRC, medical organizations have updated their screening guidelines. The U.S. Preventive Services Task Force (USPSTF) and the American Cancer Society (ACS) now recommend that most adults begin regular colorectal cancer screening at age 45, five years earlier than previously recommended.

Screening options include:

• Colonoscopy: Considered the "gold standard" for screening, colonoscopy involves a visual examination of the colon and rectum using a flexible tube with a camera. It allows for the detection and removal of precancerous polyps.
• Stool-based tests: These tests look for signs of cancer in a person's stool. Options include the fecal immunochemical test (FIT), the guaiac-based fecal occult blood test (gFOBT), and the multi-targeted stool DNA test (MT-sDNA). A recent RCT illustrates FIT used for CRC screening (annual FIT for 3 years) detected all CRCs and was equivalent to colonoscopy for detecting advanced neoplasia in first-degree relatives of patients with CRC.
• Flexible sigmoidoscopy: This procedure examines the rectum and lower part of the colon.

Individuals with an increased risk of colorectal cancer, such as those with a family history or inflammatory bowel disease, may need to start screening earlier and undergo more frequent testing.

Impact and Future Directions

The rise in EOCRC has significant implications for individuals, families, and the healthcare system. Younger patients diagnosed with colorectal cancer may face unique challenges, including career interruptions, financial strain, and concerns about fertility.

Researchers are actively working to better understand the causes of EOCRC and develop more effective prevention and treatment strategies. Areas of focus include:

• Identifying specific genetic and environmental factors that contribute to the disease.
• Developing new screening methods to detect cancer at earlier stages.
• Tailoring treatment approaches to the specific characteristics of EOCRC.

A Call to Action

The increasing rates of colorectal cancer in younger adults is a serious public health concern. Increased awareness of risk factors and symptoms, along with adherence to recommended screening guidelines, are essential for early detection and improved outcomes. Individuals of all ages should prioritize a healthy lifestyle, including a balanced diet, regular exercise, and avoiding tobacco and excessive alcohol consumption. Anyone experiencing concerning symptoms should promptly consult with a healthcare provider.